Skip to content

Scope of Homoeopathy in menstrual disturbances of adolescent girls

Scope of Homoeopathy in menstrual disturbances of adolescent girls – A Multi-centric, Prospective study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068833
Enrollment
240
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E288- Other ovarian dysfunction Health Condition 2: E289- Ovarian dysfunction, unspecified Health Condition 3: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Individualized Homoeopathic medicines (however not limited to)- Ammonium carb, Ambra gresia, Argentum nitricum, Aurum met, Belladona, Calcarea carb, Carbo veg, Carboneum sulph, Causticu

Sponsors

CENTRAL COUNCIL FOR RESEARCH IN HOMOEOPATHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Unmarried Females in the age group 12 to 18 years. 2. Females with menstrual abnormalities like amenorrhea, oligomenorrhoea, dysmenorrhoea, dysfunctional uterine bleeding. 3. Females not undergoing conventional treatment or any hormonal therapy. 4. Females who have given the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Female below the age of 12 years and above the age of 18 years. 2. Females with abnormal findings on levels of Prolactin, TSH, T3, T4. 3. Females taking conventional treatment or any hormonal therapy. 3. Females taking medication for any other severe illness. 4. Females during pregnancy and lactation. 5. Females with no written informed consent.

Design outcomes

Primary

MeasureTime frame
• Clinical Assessment using MYMOP2, ORIDL at every month up to 12 months • Adolescent health assessment using WHO-5 index and Warwick-Edinburgh Mental Wellbeing scaleTimepoint: • Every month, upto 12 months. • Baseline, 3 months, 6 months, 9 months and 12 months.

Secondary

MeasureTime frame
• Assessment of serum levels of LH, FSH, Oestradiol, free Testosterone, Dehydroepiandrosterone (DHEA), Prolactin, TSH, T3, T4, Lipid profile, Glucose tolerance test, Ultrasonography of abdomen and pelvisTimepoint: Baseline, 6th month and 12th month.

Countries

India

Contacts

Public ContactDr Manas R Sarangi
drmanas2k@gmail.com9968091251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026